职位

Intellia

Intellia

Intellia

Focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.

Gene Editing

CRISPR Technology

Cell Engineering

Bioinformatics

Drug Development

Cambridge, Middlesex County

201-500

2014年成立(第12年)

混合办公

Public

估值

$1.2B

融资总额

$70M

最近融资

Series B

NTLA

$12.84

Intellia在招职位

0个在招职位

目前没有在招职位

已关闭职位

4个职位

Our Culture

Remote

已关闭 6个月前

ONE Intellia

Remote

已关闭 6个月前

Join Us

Remote

已关闭 6个月前

Careers

Remote

已关闭 6个月前

产品与服务

CR

CRISPR/Cas9 Gene Editing Platform

Gene Editing Technology

NT

NTLA-2001

Gene Editing Therapy

NT

NTLA-3001

Gene Editing Therapy

EX

Ex Vivo Cell Engineering

Cell Engineering Service

NT

NTLA-2002

Gene Editing Therapy

NE

Neurological Disease Programs

Gene Editing Therapy

PR

Primary Hyperoxaluria Program

Gene Editing Therapy

MO

Modular CRISPR Platform

Platform Technology

AS

ASGR1 Program

Gene Editing Therapy

IN

In Vivo Gene Editing Services

Gene Editing Service

LI

Lipid Nanoparticle Delivery System

Drug Delivery Technology

NTLA-5001

NTLA-5001

Cell Therapy

IM

Immunology Pipeline

Therapeutic Pipeline

NTLA-2003

NTLA-2003

Gene Editing Therapy

Asgard Platform

Asgard Platform

Platform Technology

LI

Lipid Nanoparticle Platform

Technology Platform

ON

Oncology Cell Therapies

Cell Therapy

Engineered Cell Medicines

Engineered Cell Medicines

Cell Therapy

CR

CRISPR Platform Technology

Technology Platform

浏览量

4

申请点击

0

模拟申请

0

收藏

0

评价

2.7

2条评价

工作生活平衡

3.0

薪酬

3.0

企业文化

2.0

职业发展

2.5

管理层

1.5

25%

推荐率

优点

Potential for meaningful medical impact

Working on innovative treatments

Opportunity to help patients with rare diseases

缺点

Poor management decisions

Unfair layoff practices

Favoritism in promotions

薪资范围

47个数据点

Mid/L4

1份报告

-

年薪总额

基本工资

$165,000

股票

-

联系方式与地址